Cite
HARVARD Citation
Wakabayashi, H. et al. (2021). The regulatory approval of anamorelin for treatment of cachexia in patients with non‐small cell lung cancer, gastric cancer, pancreatic cancer, and colorectal cancer in Japan: facts and numbers.. Journal of cachexia, sarcopenia and muscle. 12 (1), pp. 14-16. [Online].